Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NZ Plans Revamp Of ‘Outdated’ Rules To Attract More Trials

This article was originally published in PharmAsia News

Executive Summary

As part of its planned overhaul of the regulatory framework for medicines and medical devices, the New Zealand government says it intends to 'realize New Zealand's potential as a clinical trial destination' by updating the clinical trial regulations in line with international norms, and extending trial oversight to all therapeutic products.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

SC089541

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel